We observed a decrease in cell growth for both TDR cell lines versus the control after SOD2 knockdown, suggesting that SOD2 could be a factor in modulating tumor proliferation and survival in trametinib- and dabrafenib-resistant (TDR) melanoma cell lines (Figure 5B,C). This evidence concerns the gene SOD2 and neoplasm.